NCT01040585View on ClinicalTrials.gov

Cost Effectiveness Of Linezolid In Central America

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

July 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Ventilator Acquired Pneumonia
Interventions
DRUG

Linezolid

Treatment for VAP as indication approved and as physician criterium.

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY